Inhalation Sciences gets PreciseInhale order from Westchina-Frontier Pharma Tech Co. Ltd. (WCFP), a leading Chinese CRO.
Inhalation Sciences (ISAB) has received an order from the Chinese CRO Westchina-Frontier Pharma Tech Co,. Ltd.(WCFP) on a PreciseInhale system, including its modules for in vivo studies. The order value is initially approx. 1.2 MSEK.
Westchina-Frontier Pharma Tech Co,. Ltd.(WCFP) is a CRO (Contract Research Organisation) located in Chengdu, Sichuan. With PreciseInhale, WCFP is broadening their offer within Inhalation research studies. WCPF is Inhalation Sciences first customer in the Asian market.
ISAB CEO Lena Heffler: “We are proud and happy to see our technology take a first step into the Chinese market. It is also exciting to see a CRO that expand their capacity to include PreciseInhale.”
For more information about Inhalation Sciences please contact: Lena Heffler, CEO Email: firstname.lastname@example.org Phone: +46 (0)70 205 96 20Press release in PDF format